Epidemiology of bacterial meningitis in the USA from 1997 to 2010: A population-based observational study

The Lancet Infectious Diseases

Volumn 14, Issue 9, 2014, Pages 813-819

  Castelblanco, Rodrigo Lopez ^a   Lee, MinJae ^b   Hasbun, Rodrigo ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; PREVNAR 7; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CHILD; COMMUNITY ACQUIRED INFECTION; CORTICOSTEROID THERAPY; EPIDEMIC MENINGITIS; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MORTALITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; OBSERVATIONAL STUDY; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, BACTERIAL; MENINGITIS, HAEMOPHILUS; MENINGITIS, MENINGOCOCCAL; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; TIME FACTORS; UNITED STATES;

EID: 84906934257     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70805-9     Document Type: Article

References (31)

1. Dery MA, Hasbun R Changing epidemiology of bacterial meningitis. Curr Infect Dis Reports 2007, 9:301-307.
2. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
3. Van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
4. De Gans J, Van de Beek D Dexamethasone in adults with bacterial meningitis. N Eng J Med 2002, 347:1549-1556. and for the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators.
5. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
6. Brouwer MC, Heckenberger SG, de Gans J, et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010, 75:1533-1539.
7. (2000) "Poisson-Based Regression Analysis of Aggregate Crime Rates. J Quant Criminol 2000, 16:21-43. Osgood.
8. Paternoster R, Brame R Multiple routes to delinquency? A test of developmental and general theories of crime. Criminology 1997, 35:45-84.
9. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009, 360:244-256.
10. Martin NG, Sadarangani M, Pollard A, et al. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis 2014, 14:397-405.
11. Okike Ifeanichukwu O, Ribeiro Sonia, Ramsay Mary E, et al. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis 2014, 14:301-307.
12. Swartz MN Bacterial meningitis-a view of the past 90 years. N Engl J Med 2004, 351:1826-1828.
13. Brouwer MC, McIntyre P, Prasad K, van de Beek D Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2013, 6. CD004405.
14. Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008, 299:2048-2055.
15. Arditi M, Mason EO, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998, 102:1087-1097.
16. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008, 46:1664-1672.
17. Bilukha OO, Rosenstein N Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2005, 54:1-21. National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention (CDC).
18. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the US. N Engl J Med 1997, 337:970-976.
19. Wenger JD, Hightower AW, Facklam RR, et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990, 162:1316-1323.
20. Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010, 50:184-191.
21. Harrison LH, Jolley KA, Shutt KA, et al. Antigenic shift and the incidence of meningococcal disease. J Infect Dis 2006, 193:1266-1274.
22. Fischer M, Hedberg K, Cardosi P, et al. Tobacco as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997, 16:979-983.
23. Norheim G, Sadarangani M, Omar O, et al. Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis. BMJ Open 2014, 4:e003312.
24. Progress toward elimination of Haemophilus influenzae Type b invasive disease among infants and children-United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002, 51:234-237. Centers for Disease Control and Prevention (CDC).
25. Morris SK, Moss WJ, Halsey N Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 2008, 8:435-443.
26. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010, 28:4073-4078.
27. van de Beek D, Drake JM, Tunkel AR Nosocomial bacterial meningitis. N Eng J Med 2010, 362:146-154.
28. Adult vaccination coverage-United States, 2010. Morb Mortal Wkly Rep 2012, 61:66-72. Centers for Disease Control and Prevention (CDC).
29. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729-1735.
30. Wilson FM, Lerner AM Etiology and mortality of purulent meningitis at the Detroit receiving hospital. N Engl J Med 1964, 271:1235-1238.
31. McMillan DA, Lin CY, Aronin SI, Quagliarello VJ Community-acquired bacterial meningitis in Adults: Categorization of causes and timing of death. Clin Infect Dis 2001, 33:969-975.